Lilly slips 4% as Q4 trails estimates; Guidance lags consensus; COVID-19 antibody revenues of $810M
April 27 2021 - 7:17AM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
Eli Lilly (NYSE:LLY)
Historical Stock Chart
From Mar 2024 to Apr 2024
Eli Lilly (NYSE:LLY)
Historical Stock Chart
From Apr 2023 to Apr 2024